Tapentadol is partially metabolized via the hepatic enzymes CYP2C9, CYP2C19, and CYP2D6 so it innately has interactions with medications that boost or repress the action/expression of a number of of such enzymes, and also with substrates of these enzymes (resulting from Opposition for that enzyme); some enzyme mediators/substrates require dosing https://carlosv691egg5.blogmazing.com/profile